Purpose The objective of this study was to determine whether cells from the conjunctiva could be reprogrammed into induced pluripotent stem (iPS) cells, providing an alternative source of stem cells. Methods We employed a doxycycline-induced reprogrammable mouse strain to generate iPS cells from conjunctiva. The identity of the stem cells was confirmed by reverse transcription polymerase chain reaction (RT-PCR) and immunofluorescence assays. Immunocytochemistry and teratoma assays are established means for scoring stem cell pluripotency. The reprogramming efficiencies of conjunctival cells and ear fibroblasts were compared. Results We confirmed the identity of the stem cells and demonstrated expression of pluripotency markers (OCT4, SOX2, NANOG, and SSEA1), as tested by RT-PCR and immunofluorescence assays. In addition, derived iPS cells differentiated successfully into embryoid bodies, and showed teratoma formation when injected into immunodeficient mice. Reprogramming conjunctival tissue is as efficient as reprogramming ear fibroblasts. Conjunctiva-iPS exhibited classic features of embryonic stem (ES) cells with respect to morphology, expression of surface antigens, and pluripotency-associated transcription factors, capacity to differentiate in vitro, and the ability to form all three germ layers in vivo. Conclusion The present study demonstrated that conjunctival cells, which are readily obtained during the course of many routine conjunctival biopsies and ophthalmic procedures, can be another reliable source of iPS cells.
Introduction
Induced pluripotent stem (iPS) cells are a useful alternative to embryonic stem (ES) cells as a source for stem cell-based therapies. These cells, derived from patients' own tissues, are expected to become a powerful tool in the arsenal of regenerative medicine. Not only have iPS cells been the object of fewer ethical controversies than ES cells, but autologous iPSbased transplants would also carry medical advantages by eliminating the pitfalls and risks of immunosuppressive therapy. Already, previous research has shown promise in rescuing degenerated retinal pigment epithelium (RPE) cells with iPS treatment in mouse models of retinal disease [1] .
Previous studies have shown it is possible to generate these multipurpose, pluripotent stem cells from various body tissues, including stomach cells [2] , liver cells [2] , pancreatic B cells [3] , lymphocytes [4] , neural progenitor cells [5, 6] , and human keratinocytes [7, 8] . Many of these experiments employed genetic labeling or other techniques to confirm the identity of donor cells. Due to the difficulty of sampling liver cells during regular physical examinations, and uncertainty whether hair cells and adipose cells are a reliable source for reprogramming [9, 10] , the search for an optimal tissue source for iPS has continued. Skin cells are still the most predominant and commonly used source of iPS. However, routine ophthalmic procedures offer numerous opportunities to take samples of other tissues, such as the conjunctiva [11] .
The conjunctiva is a thin, transparent mucous membrane that lines the posterior surface of the lid and is reflected forwards on the eye. Many ophthalmic procedures involve conjunctival biopsies, either at the diagnosis or intervention stages [11] . If conjunctival tissue is indeed reprogrammable, these biopsies could be stored and used to generate iPS at a later date. There would be no need for a subset of patients to undergo additional skin biopsies. Never before investigated as a source of iPS cells, conjunctival tissue was tested in this study to determine its availability for reprogramming. 4F2A mice (Jackson Laboratories) expressing a dox-inducible polycistronic 4F2A cassette containing the four reprogramming genes Oct4, Sox2, Klf4, and Myc from the Col1a1 locus. Somatic expression of these reprogramming factors allows multiple somatic cell types to be directly reprogrammed to generate induced pluripotent stem cells by culture with doxycycline.
Materials and methods

Mice
Conjunctiva primary cell culture
Under sterile conditions, mice were anesthetized by intraperitoneal injection with a combination of 1 % xylazine and 10 % ketamine. Eyelashes were excised from right eyes, and then both the eyelids and ocular surface were cleaned with a 5 % povidone-iodine solution and rinsed with sterile phosphate buffered saline (PBS). Subconjunctival injections of 0.2 ml PBS were administered to separate conjunctival tissue, and small samples (2 mm ×3 mm) were obtained by biopsy from the upper temporal conjunctival fornix. The conjunctiva biopsy tissue was next washed in PBS three times before dissection into explants of 1 mm×2 mm in size. Tissues were then cultured in DMEM (Dulbecco's modified Eagles's medium) supplemented with high glucose, 10 % fetal bovine serum, antibiotic (50 U/ml penicillin, 50 μg/ml streptomycin) and sodium pyruvate (all from Invitrogen, Carlsbad, CA, USA). Tissue was maintained in 1 ml tissue-culture medium for a period of 6 h until cells were attached closely to culture dishes. Then an additional 3 ml of the tissue-culture medium was added. After initial outgrowths appeared at day 7, conjunctiva cells were collected and purified for iPS cell induction. Primary conjunctival cell cultures were typically intermixed with fibroblast cells, since there are several layers of conjunctival [12] . Keratin 13 (K13) and cytokeratin 15 (CK15) are both specific markers of conjunctival epithelium [13, 14] . To confirm that these conjunctival monolayer cells did indeed include conjunctival epithelium cells, a K13 RT-PCR assay was performed. CK 15 immunofluorescence staining was also performed before and after collagenase IV purification to show the proportion of conjunctival cells that are epithelial or fibroblast in origin. The total numbers of cells were identified by immunolocalization with vimentin, which is expressed both on epithelium cells and fibroblasts [14, 15] .
Mouse ear fibroblast cell culture
Mouse ear tissue tips were collected after cleaning with a 5 % povidone-iodine solution, and were subsequently rinsed with sterile PBS. These were cut into small pieces and seeded on a dish with a cover slip to help tissue attach to the dish. A small amount of silicon oil was placed at the center of the plates to help them stick to cover slips. After initial outgrowths appeared at day 7, the cover slip was turned over and 0.25 % trypsin was added for 3 min. The medium consisting of 10 % serum to stop trypsinization was added. Fibroblast cells were fully detached from the dish with a cell scraper. After cells were centrifuged, cell pallets were suspended; within 1 min, large pieces settled to the bottom. The suspended cells were then reseeded on a dish.
iPS cell induction
Primary cultured conjunctival cells were seeded at a 2.5× 10 5 concentration per 10 cm dish for reprogramming and colony isolation. Medium was replaced with iPS medium freshly prepared and supplemented with doxycycline (dox) to a final concentration of 2 μg/ml. We also added medium without dox as a negative control. Dishes were incubated at 37°C in a 5 % CO 2 incubator. Dox was withdrawn at day 12. For efficiency comparisons, a total of eight dishes were created, derived from two separate genetically engineered mice. Four dishes of conjunctival cells and four dishes of ear fibroblast cells were derived from each of these mice. They were seeded at 1.4×10 5 concentrations per 3.5 cm dish. Mouse iPS culture medium was composed of mouse embryonic stem cells (mES) medium, 10 % ES cell grade FBS, 0.1 mmol/l nonessential amino acids, 1 mmol/l Glutamax, 0.1 mmol/l β-mercaptoethanol, 4 ng/ml of basic fibroblast growth factor (bFGF) (all from Invitrogen, Carlsbad, CA, USA), and 1,000 units/ml leukemia inhibitory factor (LIF) (Millipore, Billerica, MA, USA). Cells were cultured at 37°C in a 5 % CO 2 incubator. At day 20, colonies formed. Ideal colonies on 10-cm dishes were micro-dissected into small pieces using glass hooks. This process was repeated until passage 3, at which time colonies were picked manually and incubated in 0.25 % trypsin (Invitrogen) for 20 min at 37°C. Then colonies were dissociated into single cells and transferred to wells in 96-well plates with mouse embryonic fibroblast (MEF) feeder cells and 200 μl medium. The iPS cells were further expanded into six-well plates. After expansion to six-well plates, the cells were routinely split at a 1:6 ratio every 2-3 days. The colonies in comparison groups, in the 3.5 cm dishes, were not picked. They were cultured for alkaline phosphatase (AP) staining, which was performed in each separate 3.5 cm dish on days 20 and 25. Induction ratios of iPS cells in the conjunctival cell and ear fibroblast dishes were compared. The numbers of AP positive staining colonies were counted. Immunofluorescence staining Both ES cells with the C57BL6/J mouse background and two conjunctiva-iPS cell lines were fixed in 4 % paraformaldehyde (Sigma) in PBS for 2 h at room temperature. Anti-SSEA1, anti-SOX2, and anti-OCT4 immunofluorescence staining was performed with a mouse ES/iPS cell characterization kit (Applied StemCell). Alkaline phosphatase (AP) was tested. AP is a stem cell membrane marker whose elevated expression is associated with pluripotency [16] . This assay has been widely used to examine the differentiated/undifferentiated status of ES/iPS cells.
RT-PCR assay
RNA was isolated from conjunctiva-derived cells, two iPS cell lines and embryonic stem cells using the RNeasy kit (QIAGEN, Hilden, Germany), and genomic DNA contamination was removed using a DNA-free kit (Invitrogen). One microgram of total RNA was used for cDNA synthesis using Superscript III Reverse Transcriptase and Oligo (dT) primers (Invitrogen). PCR was performed using primers listed in Table 1 .
Karyotyping
Two iPS cell lines were arrested in metaphase by the addition of colcemid (5ul/ml, Invitrogen) to the culture medium and treated for 2 h. 0.56 % KCl solution was added after centrifuge and cells were carefully resuspended. Cells were then fixed with ice-cold 3:1 methanol: glacial acetic acid. A single drop of cell suspension was released onto clean glass microscope slides (cleaned with 70 % ethanol) from approximately 40 cm height, blown across the surface, and allowed to air dry. This was stained with Giemsa solution and put under a coverslip. Chromosomes were counted.
Results
Conjunctiva cells began growing out of a biopsy taken from R26
rtTA ; Col1a1 4F2A mice starting at day 2 ( Fig. 1) . 30 % of cells derived from the conjunctiva expressed the CK 15 epithelial marker at passage 1(P1) (Fig. 2) . The proportion of CK 15 reactive cells increases after collagenase IV treatment and replating at P2 (Fig. 2) .
iPS differentiation was initiated with doxycycline (Dox) at P2. After 3 days of dox treatment, the cells began to change shape and assume the characteristic dome-shaped, refractile colonies of iPS cells (Fig. 3b) ; in contrast, no changes were apparent in a control untreated group, except for cell growth (Fig. 3a) . On day 20, ES-like colonies had formed. Colonies in 10-cm dishes were picked for further passage (Fig. 4a) . These Fig. 7 Expression of pluripotency and differentiation markers by RT-PCR. a RT-PCR analysis confirmed reactivation of endogenous c-Myc, Sox2, Oct4, K13 and Nanog. K13 is a specific maker for conjunctival epithelium. b RT-PCR analysis of total RNA isolated from embryoid bodies (EBs) generated from conjunctival iPS lines. The expression of Nanog (a mark of pluripotency), vimentin and brachyury (mesoderm), Foxa2 (endoderm), and nestin (ectoderm) was examined. β-actin was used as a loading control. CC=conjunctival cells cells have been maintained for >10 passages (Fig. 4c) . After passages were manually picked, the cells formed compact colonies displaying a peripheral halo when observed by phase-contrast microscopy, closely resembling the formations commonly observed in mouse ES cell colonies (Fig. 4f) . The numbers of colonies per 3.5 cm dish were counted, both in conjunctival cell lines and ear fibroblast cell lines, on day 20 and day 25, after AP staining (Fig. 5) . In some cases, colonies that had formed by days 20 or 21 and were maintained in culture without subculturing became differentiated over the next 4-5 days. When those iPS colonies were stained on day 25, these were not stainable. Meanwhile, new colonies which continued to appear during these 5 days were stainable. The numbers of colonies increased dramatically and were present at similar levels in both iPS lines.
Immunofluorescence analysis showed that the iPS cell lines stained positively for OCT4, SOX2, and SSEA1, which is expected for bone fide iPS and ES cells (Fig. 6) . RT-PCR analysis confirmed reactivation of endogenous Myc, Oct 4, and Sox2 genes, as well as that of other pluripotencyassociated transcription factors such as Ssea-1 and Nanog, observable in all iPS lines tested in the study (Fig. 7a) . The positive results of K13 tests showed that some iPS cells came from counjunctival epithelial cells (Fig. 7a) . Immature gland surrounded by immature smooth muscle (endoderm). Scale bar: 100 μm Fig. 9 Normal karyotype of the two conjunctiva-induced iPS cell lines. 40 chromosomes were normal in two iPS cell lines derived from two different genetically modified mice (100×) (a and b were derived from these two mice). Scale bar: 25 μm
We next evaluated the differentiation potential of the conjunctiva-iPS in vitro by embryoid body (EB) formation and in vivo by teratoma induction. The iPS cells readily formed EBs on culture in the absence of LIF and bFGF (Fig. 4e) . RT-PCR testing of the EBs showed strong suppression of the pluripotency gene NANOG, with coincident activation of lineage-specific genes representing the three germ layers: nestin (ectoderm); vimentin and brachyury (mesoderm); and Foxa2 (endoderm) (Fig. 7b) . Each cell line was injected into three SCID mice. All six SCID mice formed teratomas. Hematoxylin-eosin staining of teratoma sections showed tissues representative of the three germ layers, including neuroepithelial cells, neuroepithelium with pigment (ectoderm), adipocytes, cartilage (mesoderm), and secretinggland epithelium (endoderm) (Fig. 8) , providing strong evidence for the pluripotency of iPS cells generated with our methods. Normal karyotypes were achieved in both conjunctiva-induced iPS cell lines (Fig. 9) .
Discussion
The present study demonstrates the feasibility of generating induced pluripotent stem (iPS) cells from the conjunctiva. The reprogrammability of conjunctival cells was determined by various assays. RT-PCR analysis confirmed the presence of pluripotency-associated transcription factors. Pluripotency markers found in iPS derived from conjunctiva are identical to those found in ES lines. The differentiation potential of the conjunctiva-iPS was tested in vitro by EB formation, and in vivo by teratoma induction. This is the first demonstration that iPS can be isolated from the conjunctival cells, adding to previous studies of iPS differentiation showing that skin and liver cells, among others, are viable sources for reprogramming.
It remains to be determined whether iPS retains some of the original qualities of donor tissues [2] . When differentiated into ocular surface tissue, it may be that conjunctiva-iPS expresses ocular surface markers with greater intensity than would typical skin fibroblasts. Future studies may investigate whether conjunctiva-iPS is a particularly effective source of ocular surface tissue. If so, this would have encouraging implications for direct reprogramming.
The mice employed in the study express the four reprogramming genes under control of a doxycyline-inducible Col1a1 promoter, R26rtTA; Col1a14F2A [17] . Previously, R26 rtTA mice have been tested for inducible target gene expression in the liver, bone marrow, stomach, intestine, and skin, all with successful results. Low levels of reprogramming gene expression were discovered in the heart, lungs, kidney, spleen, and thymus; no expression was detected in the brain and testes [17] . The reprogramming efficiencies of conjunctiva iPS cells and ear fibroblasts cells are equivalent. Thus, expression of the four reprogramming genes Oct4, Sox2, Klf4, and Myc from the Col1a1 promoter successfully yielded iPS from mouse conjunctival tissue.
Routine ophthalmic procedures offer numerous opportunities to take samples of the conjunctiva [11, 18, 19] . The anatomical location of the tissue makes it readily accessible and only a small sample may need to be taken to make iPS cells. Whenever small pieces of conjunctival tissue are taken during routine procedures, these may be placed in primary cell cultures and be kept for further use rather than discarded prematurely. Recently, it has been shown that dental pulp cells can also be used to create iPS cell banks [20] , and we have demonstrated that it is possible to generate iPS from a similarly small type of biopsy. Conjunctival cells or, alternatively, conjunctiva-iPS cells may be stored in a freezer bank for use in the future. Suitable candidates for conjunctival tissue sampling are wet AMD patients and diabetic patients who require ophthalmic procedures. These patients may benefit from iPSbased regenerative medicine treatments in the future.
